A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...

March is a significant month for women's health, observing International Women's Day and National Women's HIV/AIDS Awareness ...

Federal datasets began disappearing from public view on Jan 31, in response to executive orders from President Donald Trump.

Debates over tuberculosis reporting began in the late 19th century, when the bacterial infection was reframed not as a disease of the elite but of the urban poor. New York City was the first in the ...

The advent of effective antiretroviral therapy (ART) has increased the lifespan of many people living with HIV. As a result, ...

However, hope may be on the horizon as a radical new drug has potential to be released if it passes all trials. Lenacapavir, ...

Prevalence varies by region and is impacted by social stigma, access to preventive medicine and a lack of HIV/AIDS education, ...

The U.S. faces an ongoing HIV epidemic, with women, particularly women of color, bearing a heavy burden. While there have ...

Millions of people worldwide are likely to lose access to anti HIV drugs, and thousands more people could die, after the US ...

In the wake of US funding cuts for global aid, numerous donor-funded health facilities in South Africa have shut down and ...

The National Agency for the Control of AIDS has described information in sections of the media regarding the withdrawal of ...

The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about ...